$CTSH

Kerdman Alina sold $5K of CTSH

Kerdman Alina (SVP, Controller & CAO) sold 137 shares of COGNIZANT TECHNOLOGY SOLUTIONS CORP (CTSH) at $39.82 on 2026-07-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Kerdman Alina
Published Jul 6, 2026, 8:05 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 6, 2026, 8:15 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CTSH
Neutral
high confidence
Mentioned
$CTSH
Relevance
2/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CTSHNeutralLow
01

Why it matters

This updates the insider trading timeline: Kerdman Alina (SVP, Controller & CAO) sold 137 shares at $39.8200/share on 2026-07-01 under a pre-arranged Rule 10b5-1 plan; holdings after sale were 992 shares.

02

Market read

Primarily informational for insider-trading trackers; unlikely to drive a meaningful repricing given the small size and 10b5-1 structure.

03

What to watch

The filing does not indicate intent beyond the pre-arranged plan; the dollar value is small, reducing interpretive power.

Relevance 2/10Novelty 3/10Timing: Filed on 2026-07-06 after the sale on 2026-07-01.

Background

The article is an SEC Form 4 insider transaction disclosure for Cognizant Technology Solutions Corp (CTSH).

Company-level read

Ticker impact

$CTSHNeutralHigh confidence
Context

SEC Form 4 shows Cognizant insider Kerdman Alina sold 137 shares at $39.82 on a 10b5-1 plan, disclosing new transaction details.

Expected impact

Low likelihood of a sustained price move from this specific sale; any reaction would be sentiment-driven and typically muted.

Evidence & confidence

The filing is a disclosed open-market sale under a pre-arranged 10b5-1 plan, with small share count ($5.5k) relative to the company.

Market effects

Minimal—this is company-specific insider transaction data with no sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

Even 10b5-1 sales can coincide with periods of internal de-risking; traders may still watch for follow-on insider activity.

Key entities

  • CTSH

    Cognizant Technology Solutions Corp, issuer of the Form 4 insider sale.

  • Kerdman Alina

    SVP, Controller & CAO; reported open-market sale under a 10b5-1 plan.

Related articles

$CTSHMed

Anthropic Is Only Part of the Story. Cognizant Has a Much Bigger AI Plan.

Cognizant (CTSH) trades at a discount versus its historical valuation, with forward GAAP P/E of 8.31x and P/S of 0.97x. In Q2, it reported EPS $1.37 vs $1.38 expected, 4.5% revenue growth, and $459M free cash flow. Management guided Q3 growth 3.8%-5.3% YoY and FY EPS to $5.76 midpoint. Guggenheim cut its price target to $65 but kept a Buy; analysts’ mean target is $60.12.

$CTSHMedAI 8/10

Cognizant Technology Solutions Corporation Q2 2026 Earnings Call Summary

Cognizant Technology Solutions reported 4.1% year-over-year constant-currency revenue growth in Q2 2026, driven by North America and 12% growth in financial services. The company revised full-year revenue guidance to 4% to 5.5% growth and kept adjusted operating margin at 16% to 16.2%. It cited an $81M one-time India benefit, Project LEAP costs, and interest expense after a $1B Astreya-related draw.

$CTSHMed

Cognizant Earnings: Financial Services and North America Drive Resilient Performance

Morningstar’s stock note says Cognizant (CTSH) reported 4% Q2 constant-currency revenue growth, with operating margin steady at 16% and trailing 12-month bookings up 5%. It attributes results to North America and financial services, where growth was 12%. Morningstar keeps a $84 fair value estimate and 16.0%-16.2% operating margin guidance, while trimming full-year revenue growth outlook to 4.0%-5.5%.